Drug profile · INN
remifentanil hydrochloride
REMIFENTANIL HYDROCHLORIDE
remifentanil hydrochloride (REMIFENTANIL HYDROCHLORIDE) is a mu opioid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — remifentanil hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 20
- Programs
- 2
- Data quality
- 0.84
Quick answer
remifentanil hydrochloride (REMIFENTANIL HYDROCHLORIDE) is a mu opioid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Mu opioid receptor agonist
Primary target: Mu-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 2025129145
BI- AND MULTIVALENT ALBUMIN BINDERS
granted -
US 12269155
Multivalent vaccines for rabies virus and coronaviruses
granted -
US 12227584
Multivalent and multispecific OX40-binding fusion proteins
granted -
US 12187804
Multivalent and multispecific 41BB-binding proteins
granted -
US 11976126
Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells
granted -
US 11938221
Multivalent nanoparticle-based vaccines
granted -
US 11235054
Multivalent vaccine composition
granted -
US 11191727
Multivalent nanoparticle-based vaccines
granted -
US 11117973
Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasms
granted -
US 11117972
Multivalent and multispecific OX40-binding fusion proteins
granted -
US 11041170
Multivalent vaccines for rabies virus and coronaviruses
granted -
US 10849975
Multivalent vaccines for rabies virus and filoviruses
granted -
US 10844129
Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acids
granted -
US 10738275
Paenibacillus sp. strain, cultivation method and use of the same
granted -
US 10610492
Spray dry method for encapsulation of biological moieties and chemicals in polymers cross-linked by multivalent ions for controlled release applications
granted -
US 10501551
Multivalent and multispecific 41BB-binding fusion proteins
granted -
US 10472412
Bispecific multivalent fusion proteins
granted -
US 10420811
Cultivation of selenium-rich Cyclocarya paliurus plant, extraction and use of active ingredients thereof
granted -
US 10308720
Multivalent and multispecific DR5-binding fusion proteins
granted -
US 10113145
Paenibacillus sp. strain, cultivation method and use of the same
granted
Frequently asked questions
What is remifentanil hydrochloride?
remifentanil hydrochloride (REMIFENTANIL HYDROCHLORIDE) is a mu opioid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for remifentanil hydrochloride?
REMIFENTANIL HYDROCHLORIDE is a marketed brand name for remifentanil hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of remifentanil hydrochloride?
remifentanil hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.